Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

NCT03940183 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Trelagliptin Succinate
DRUG: Placebo Oral Tablet

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.